https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=Avidity_Biosciences%2C_Inc. 2026-05-09T10:09:23Z Istoricul versiunilor pentru această pagină din wiki MediaWiki 1.39.2 https://wiki.tradeville.ro/index.php?title=Avidity_Biosciences,_Inc.&diff=448999&oldid=prev 2024-10-03T02:57:49Z

<p>The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).</p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="ro"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Versiunea anterioară</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Versiunea de la data 3 octombrie 2024 05:57</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l2">Linia 2:</td> <td colspan="2" class="diff-lineno">Linia 2:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Descriere companie==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Descriere companie==</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Avidity Biosciences, Inc. (http://www.aviditybiosciences.com/) is a biopharmaceutical company. The Company focuses on oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC), designed to overcome the limitations of oligonucleotide-based therapies to treat a range of serious diseases. It utilizes its AOC platform to design, engineer and develop therapeutics that combine the tissue selectivity of monoclonal antibodies (mAbs) and the precision of oligonucleotide-based therapies. The Oligonucleotide therapeutics are designed based on genomic information to specifically inhibit or modify the expression of disease-related proteins and ribonucleic acids (RNA). It is focused on muscle diseases and consists of approximately five programs. Its lead product candidate, AOC 1001, is designed to treat myotonic dystrophy type one (DM1). It also focuses on other muscle programs focused on the treatment of facioscapulohumeral muscular dystrophy (FSHD), Duchenne muscular dystrophy, muscle atrophy and Pompe disease.</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Avidity Biosciences, Inc. (http://www.aviditybiosciences.com/) is a biopharmaceutical company. The Company focuses on oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC), designed to overcome the limitations of oligonucleotide-based therapies to treat a range of serious diseases. It utilizes its AOC platform to design, engineer and develop therapeutics that combine the tissue selectivity of monoclonal antibodies (mAbs) and the precision of oligonucleotide-based therapies. The Oligonucleotide therapeutics are designed based on genomic information to specifically inhibit or modify the expression of disease-related proteins and ribonucleic acids (RNA). It is focused on muscle diseases and consists of approximately five programs. Its lead product candidate, AOC 1001, is designed to treat myotonic dystrophy type <ins style="font-weight: bold; text-decoration: none;">[[</ins>one<ins style="font-weight: bold; text-decoration: none;">]] </ins>(DM1). It also focuses on other muscle programs focused on the treatment of facioscapulohumeral muscular dystrophy (FSHD), Duchenne muscular dystrophy, muscle atrophy and Pompe disease.</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Grafic actiuni companie==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Grafic actiuni companie==</div></td></tr> <!-- diff cache key tradeville_wiki:diff::1.12:old-438735:rev-448999 --> </table>

127.0.0.1 https://wiki.tradeville.ro/index.php?title=Avidity_Biosciences,_Inc.&diff=438735&oldid=prev 2024-09-18T18:25:54Z

<p>Pagină nouă: Pagina dedicata companiei Avidity Biosciences, Inc. listata cu simbolul US.RNA ==Descriere companie== Avidity Biosciences, Inc. (http://www.aviditybiosciences.com/) is a biopharmaceutical company. The Company focuses on oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC), designed to overcome the limitations of oligonucleotide-based therapies to treat a range of serious diseases. It utilizes its AOC platform to design, engineer and develop therap...</p> <p><b>Pagină nouă</b></p><div>Pagina dedicata companiei Avidity Biosciences, Inc. listata cu simbolul US.RNA<br /> <br /> ==Descriere companie==<br /> Avidity Biosciences, Inc. (http://www.aviditybiosciences.com/) is a biopharmaceutical company. The Company focuses on oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC), designed to overcome the limitations of oligonucleotide-based therapies to treat a range of serious diseases. It utilizes its AOC platform to design, engineer and develop therapeutics that combine the tissue selectivity of monoclonal antibodies (mAbs) and the precision of oligonucleotide-based therapies. The Oligonucleotide therapeutics are designed based on genomic information to specifically inhibit or modify the expression of disease-related proteins and ribonucleic acids (RNA). It is focused on muscle diseases and consists of approximately five programs. Its lead product candidate, AOC 1001, is designed to treat myotonic dystrophy type one (DM1). It also focuses on other muscle programs focused on the treatment of facioscapulohumeral muscular dystrophy (FSHD), Duchenne muscular dystrophy, muscle atrophy and Pompe disease.<br /> <br /> ==Grafic actiuni companie==<br /> &lt;iframe key=&quot;tradeville&quot; path=&quot;graficSimbol/US.RNA&quot; /&gt;<br /> <br /> ==Ultimele stiri despre Avidity Biosciences, Inc. (US.RNA)==<br /> &lt;dynamicpagelist&gt;<br /> category=US.RNA<br /> count=10<br /> order=descending<br /> addfirstcategorydate=false<br /> &lt;/dynamicpagelist&gt;<br /> <br /> [[Categorie:US.RNA]][[Categorie:Stiri despre companii]]</div>

Admin